Conor Cullinane net worth
Quick answer
Conor Cullinane's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Conor Cullinane is Founder at Pirouette Pharma. Pirouette Pharma valuation.
Conor Cullinane is Founder at Pirouette Pharma (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 9
- Website: https://www.pirouettepharma.com/
Who is Conor Cullinane?
Conor Cullinane is a co-founder of Pirouette Pharma, which was part of Y Combinator's S21 cohort.
Highlights:
- University of California, Berkeley
- Y Combinator S21
- Pirouette Pharma
About Pirouette Pharma
At Pirouette, we have developed a low-profile, disk-shaped, rugged injection device with a patient-centric focus on affordability, portability, and usability. The patented device, based on extensive patient input, is designed to make administering an injection as easy as pushing a button. This allows individuals with limited or no training to easily and intuitively perform an injection on themselves or others.
FAQ: Conor Cullinane net worth and Pirouette Pharma valuation
What is Conor Cullinane's net worth?
Conor Cullinane's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Conor Cullinane is Founder at Pirouette Pharma. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Pirouette Pharma valuation?
Pirouette Pharma's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Conor Cullinane's role?
Conor Cullinane is Founder at Pirouette Pharma, a Y Combinator-backed startup (batch S21).